Sept. 17, 2025 — Imperative Care recently announced positive efficacy and safety results from the pivotal Symphony-PE ...
Sept. 8, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Microbot Medical's Liberty ...
Sept. 17, 2025 — Barbara Riegel, Ph.D., R.N., FAHA, Emerita Edith Clemmer Steinbright Professor of Gerontology at the ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Sept. 16, 2025 — PaceMate has appointed Sean Shoffstall as Head of AI, Innovation and Data Strategy. Shoffstall joins ...
Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...
Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable ...
Sept. 2, 2025 — Although cardiovascular disease is a leading cause of death for women, they remain underrepresented in ...
Sept. 9, 2025 — The John Ritter Foundation for Aortic Health, a nonprofit dedicated to raising awareness, advancing ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Sept. 9, 2025 — The American Venous Forum (AVF), International Society on Thrombosis and Haemostasis (ISTH), National ...
Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
Sept. 04, 2025 — CorVista Health has published a new case series in the Journal of the American College of Cardiology ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Sept. 9, 2025 — Neurescue ApS has received CE Mark approval for its Neurescue device, a medical device approved to treat ...
Sept. 8, 2025 — GE HealthCare recently announced a Distribution and Services Agreement (DSA) with CardioNavix, a part of ...
Sept. 8, 2025 — Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation ...
September 18, 2025
